Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ENTERPRISE THERAPEUTICS HOLDINGS LIMITED

Company number 12868901

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Oct 2020 SH03 Purchase of own shares.
16 Oct 2020 SH06 Cancellation of shares. Statement of capital on 5 October 2020
  • GBP 193.479600
16 Oct 2020 SH02 Sub-division of shares on 5 October 2020
16 Oct 2020 MA Memorandum and Articles of Association
16 Oct 2020 MA Memorandum and Articles of Association
16 Oct 2020 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES13 ‐ Subdivided 05/10/2020
  • RES01 ‐ Resolution of adoption of Articles of Association
16 Oct 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
16 Oct 2020 SH08 Change of share class name or designation
08 Oct 2020 SH01 Statement of capital following an allotment of shares on 5 October 2020
  • GBP 193.4796
08 Oct 2020 SH01 Statement of capital following an allotment of shares on 5 October 2020
  • GBP 184.75014
08 Oct 2020 SH01 Statement of capital following an allotment of shares on 5 October 2020
  • GBP 159.05842
07 Oct 2020 PSC08 Notification of a person with significant control statement
07 Oct 2020 PSC07 Cessation of Philip James Boyd as a person with significant control on 5 October 2020
07 Oct 2020 TM01 Termination of appointment of Philip James Boyd as a director on 5 October 2020
07 Oct 2020 AP01 Appointment of Dr Johnathan Craig Richardson as a director on 5 October 2020
07 Oct 2020 AP01 Appointment of Mr Amit Munshi as a director on 5 October 2020
07 Oct 2020 AP01 Appointment of Dr Geert-Jan Mulder as a director on 5 October 2020
07 Oct 2020 AP01 Appointment of Dr Alexander Volker Mayweg as a director on 5 October 2020
07 Oct 2020 AP01 Appointment of Dr John William Ford as a director on 5 October 2020
07 Oct 2020 AP01 Appointment of Dr Peter Michael Finan as a director on 5 October 2020
07 Oct 2020 AP01 Appointment of Mr Bart Dzikowski as a director on 5 October 2020
05 Oct 2020 SH20 Statement by Directors
05 Oct 2020 SH19 Statement of capital on 5 October 2020
  • GBP 96.739800
05 Oct 2020 CAP-SS Solvency Statement dated 05/10/20
05 Oct 2020 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share premium account 05/10/2020
  • RES09 ‐ Resolution of authority to purchase a number of shares